SanegeneBio
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
300 Tradecenter Ste 5500, Woburn, Massac...Website
www.sanegenebio.comRevenue
$14.8 MillionIndustry
About SanegeneBio
SanegeneBio is a global, venture-backed, fully-integrated biotechnology company focused on developing RNAi-based therapeutics. Founded in 2021 and led by a team of RNAi veterans, the company has R&D operations in Boston, Shanghai and Suzhou. Their clear vision is that RNAi technology will power blockbuster medicines in diverse therapeutic areas, improving the quality and longevity of life for patients worldwide. This vision is being realized by advancing a fast-growing pipeline, which includes experimental medicines for autoimmune nephropathies, obesity, and cardiometabolic indications. SanegeneBio has initiated clinical trials for four experimental medicines to-date, and is committed to developing potential best-in-class and first-in-class therapeutics which leverage the company's industry-leading and differentiated LEAD tissue-selective RNAi delivery technology.Explore more
SanegeneBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to SanegeneBio
Compare insights from companies similar to SanegeneBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SanegeneBio
$14.8M
51-200
Private
$110M
2021
MA
Marc AbramsHead Chief Technology Officer, Operations (US)
SanegeneBio Tech Stack
A closer look at the technologies used by SanegeneBio
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SanegeneBio
Sign Up For FreeTo access detailed company insights
SanegeneBio is a global, venture-backed, fully-integrated biotechnology company focused on developing RNAi-based therapeutics. Founded in 2021 and led by a team of RNAi veterans, the company has R&D operations in Boston, Shanghai and Suzhou. Their clear vision is that RNAi technology will power blockbuster medicines in diverse therapeutic areas, im... Read More
